Review of Xtampza® ER Published in The Journal of the American Medical AssociationEconoTimes09, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced the publication of an independent review of Xtampza® ER in The Journal of the American Medical Association (JAMA). The review titled, “A New Abuse-Deterrent Opioid–Xtampza ...and more »